Search
Remedy Cell
Remedy Cell is a clinical-stage biopharmaceutical company advancing a novel class of cell-derived, cell-free therapies designed to address significant unmet needs in fibrotic diseases. The company’s lead program, RC-0315, is currently in a Phase 1b clinical trial for Idiopathic Pulmonary Fibrosis (IPF), a severe and underserved condition with limited therapeutic options. Backed by an experienced leadership team, world-class ...
Source of information:
remedycell.com
Add to My List
Key Executives
Ayelet Dilion Mashiah
CEO
Dr. Michael Timaner
VP R&D and Inventor
Prof. Yuval Shaked, PhD
Co-founder and Chief Scientific Advisor
Industries